The human respiratory syncytial virus matrix protein is required for maturation of viral filaments

Journal of Virology

Volumn 86, Issue 8, 2012, Pages 4432-4443

  Mitra, Ruchira ^a   Baviskar, Pradyumna ^a   Duncan Decocq, Rebecca R ^a   Patel, Darshna ^a   Oomens, Antonius G P ^a  

^a OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; HYBRID PROTEIN; MATRIX PROTEIN; VIRUS NUCLEOPROTEIN;

ARTICLE; BINDING SITE; CELL ELONGATION; CELL SURFACE; COMPLEX FORMATION; FIELD EMISSION SCANNING ELECTRON MICROSCOPY; HEP 2 CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROGENY; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; PROTEIN SYNTHESIS; PROTEIN TRANSPORT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VERO CELL; VIROGENESIS; VIRUS ASSEMBLY; VIRUS INCLUSION; VIRUS REPLICATION;

ANIMALS; CELL LINE; CELL SURFACE EXTENSIONS; CERCOPITHECUS AETHIOPS; CODON; GENE EXPRESSION; GENE ORDER; HUMANS; MUTATION; OPEN READING FRAMES; PROTEIN TRANSPORT; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; VIRAL MATRIX PROTEINS; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS;

EID: 84861364966     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.06744-11     Document Type: Article

References (60)

1. Bachi T, Howe C. 1973. Morphogenesis and ultrastructure of respiratory syncytial virus. J. Virol. 12:1173-1180.
2. Batonick M, Oomens AG, Wertz GW. 2008. Human respiratory syncytial virus glycoproteins are not required for apical targeting and release from polarized epithelial cells. J. Virol. 82:8664-8672.
3. Batonick M, Wertz GW. 2011. Requirements for human respiratory syncytial virus glycoproteins in assembly and egress from infected cells. Adv. Virol. 2011:pii=34308.
4. Bitko V, Oldenburg A, Garmon NE, Barik S. 2003. Profilin is required for viral morphogenesis, syncytium formation, and cell-specific stress fiber induction by respiratory syncytial virus. BMC Microbiol. 3:9.
5. Branigan PJ, et al. 2005. Use of a novel cell-based fusion reporter assay to explore the host range of human respiratory syncytial virus F protein. Virol. J. 2:54.
6. Brock SC, Goldenring Jr, Crowe JE, Jr. 2003. Apical recycling systems regulate directional budding of respiratory syncytial virus from polarized epithelial cells. Proc. Natl. Acad. Sci. U. S. A. 100:15143-15148.
7. Brock SC, Heck JM, McGraw PA, Crowe JE, Jr. 2005. The transmembrane domain of the respiratory syncytial virus F protein is an orientationindependent apical plasma membrane sorting sequence. J. Virol. 79: 12528-12535.
8. Brown G, Aitken J, Rixon HW, Sugrue RJ. 2002. Caveolin-1 is incorporated into mature respiratory syncytial virus particles during virus assembly on the surface of virus-infected cells. J. Gen. Virol. 83:611-621.
9. Brown G, et al. 2004. Analysis of the interaction between respiratory syncytial virus and lipid-rafts in Hep2 cells during infection. Virology 327:175-185.
10. Bukreyev A, Whitehead SS, Murphy BR, Collins PL. 1997. Recombinant respiratory syncytial virus from which the entire SH gene has been deleted grows efficiently in cell culture and exhibits site-specific attenuation in the respiratory tract of the mouse. J. Virol. 71:8973-8982.
11. Burke E, Dupuy L, Wall C, Barik S. 1998. Role of cellular actin in the gene expression and morphogenesis of human respiratory syncytial virus. Virology 252:137-148.
12. Cathomen T, Naim HY, Cattaneo R. 1998. Measles viruses with altered envelope protein cytoplasmic tails gain cell fusion competence. J. Virol. 72:1224-1234.
13. Chen BJ, Lamb RA. 2008. Mechanisms for enveloped virus budding: can some viruses do without an ESCRT? Virology 372:221-232.
14. Collins PL, Huang YT, Wertz GW. 1984. Nucleotide sequence of the gene encoding the fusion (F) glycoprotein of human respiratory syncytial virus. Proc. Natl. Acad. Sci. U. S. A. 81:7683-7687.
15. Couch RB, Englund JA, Whimbey E. 1997. Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med. 102:2-9.
16. Fuchs H, Bachi T. 1975. Scanning electron microscopical demonstration of respiratory syncytial virus antigens by immunological markers. J. Ultrastruct. Res. 52:114-119.
17. Garcia J, Garcia-Barreno B, Vivo A, Melero JA. 1993. Cytoplasmic inclusions of respiratory syncytial virus-infected cells: formation of inclusion bodies in transfected cells that coexpress the nucleoprotein, the phosphoprotein, and the 22K protein. Virology 195:243-247.
18. Ghildyal R, Baulch-Brown C, Mills J, Meanger J. 2003. The matrix protein of human respiratory syncytial virus localises to the nucleus of infected cells and inhibits transcription. Arch. Virol. 148:1419-1429.
19. Ghildyal R, Ho A, Jans DA. 2006. Central role of the respiratory syncytial virus matrix protein in infection. FEMS Microbiol. Rev. 30: 692-705.
20. Ghildyal R, et al. 2005. Interaction between the respiratory syncytial virus G glycoprotein cytoplasmic domain and the matrix protein. J. Gen. Virol. 86:1879-1884.
21. Ghildyal R, Mills J, Murray M, Vardaxis N, Meanger J. 2002. Respiratory syncytial virus matrix protein associates with nucleocapsids in infected cells. J. Gen. Virol. 83:753-757.
22. Gower TL, et al. 2005. RhoA signaling is required for respiratory syncytial virus-induced syncytium formation and filamentous virion morphology. J. Virol. 79:5326-5336.
23. Haas J, Park EC, Seed B. 1996. Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol. 6:315-324.
24. Han LL, Alexander JP, Anderson LJ. 1999. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Infect. Dis. 179:25-30.
25. Harrison MS, Sakaguchi T, Schmitt AP. 2010. Paramyxovirus assembly and budding: building particles that transmit infections. Int. J. Biochem. Cell Biol. 42:1416-1429.
26. Heminway BR, et al. 1994. Analysis of respiratory syncytial virus F, G, and SH proteins in cell fusion. Virology 200:801-805.
27. Henderson G, Murray J, Yeo R. 2002. Sorting of the respiratory syncytial virus matrix protein into detergent-resistant structures is dependent on cell-surface expression of the glycoproteins. Virology 300:244.
28. Huang YT, Collins PL, Wertz GW. 1985. Characterization of the 10 proteins of human respiratory syncytial virus: identification of a fourth envelope-associated protein. Virus Res. 2:157-173.
29. Inoue M, et al. 2003. A new Sendai virus vector deficient in the matrix gene does not form virus particles and shows extensive cell-to-cell spreading. J. Virol. 77:6419-6429.
30. Jeffree CE, et al. 2007. Ultrastructural analysis of the interaction between F-actin and respiratory syncytial virus during virus assembly. Virology 369:309-323.
31. Jeffree CE, Rixon HW, Brown G, Aitken J, Sugrue RJ. 2003. Distribution of the attachment (G) glycoprotein and GM1 within the envelope of mature respiratory syncytial virus filaments revealed using field emission scanning electron microscopy. Virology 306:254-267.
32. Kallewaard NL, Bowen AL, Crowe JE, Jr. 2005. Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology 331:73-81.
33. Latiff K, Meanger J, Mills J, Ghildyal R. 2004. Sequence and structure relatedness of matrix protein of human respiratory syncytial virus with matrix proteins of other negative-sense RNA viruses. Clin. Microbiol. Infect. 10:945-948.
34. Levine S, Klaiber-Franco R, Paradiso PR. 1987. Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus. J. Gen. Virol. 68:2521-2524.
35. Li D, et al. 2008. Association of respiratory syncytial virusMprotein with viral nucleocapsids is mediated by the M2-1 protein. J. Virol. 82:8863-8870.
36. McCurdy LH, Graham BS. 2003. Role of plasma membrane lipid microdomains in respiratory syncytial virus filament formation. J. Virol. 77:1747-1756.
37. McPhee HK, et al. 2011. Influence of lipids on the interfacial disposition of respiratory syncytical [sic] virus matrix protein. Langmuir 27:304-311.
38. Money VA, McPhee HK, Mosely JA, Sanderson JM, Yeo RP. 2009. Surface features of a Mononegavirales matrix protein indicate sites of membrane interaction. Proc. Natl. Acad. Sci. U. S. A. 106:4441-4446.
39. Morton CJ, et al. 2003. Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assay. Virology 311:275-288.
40. Mottet-Osman G, et al. 2007. Suppression of the Sendai virus M protein through a novel short interfering RNA approach inhibits viral particle production but does not affect viral RNA synthesis. J. Virol. 81:2861-2868.
41. Norrby E, Marusyk H, Orvell C. 1970. Morphogenesis of respiratory syncytial virus in a green monkey kidney cell line (Vero). J. Virol. 6:237-242.
42. Oomens AG, Bevis KP, Wertz GW. 2006. The cytoplasmic tail of the human respiratory syncytial virus F protein plays critical roles in cellular localization of the F protein and infectious progeny production. J. Virol. 80:10465-10477.
43. Oomens AG, Megaw AG, Wertz GW. 2003. Infectivity of a human respiratory syncytial virus lacking the SH, G, and F proteins is efficiently mediated by the vesicular stomatitis virus G protein. J. Virol. 77:3785-3798.
44. Oomens AG, Wertz GW. 2004. The baculovirus GP64 protein mediates highly stable infectivity of a human respiratory syncytial virus lacking its homologous transmembrane glycoproteins. J. Virol. 78: 124-135.
45. Oomens AG, Wertz GW. 2004. trans-Complementation allows recovery of human respiratory syncytial viruses that are infectious but deficient in cell-to-cell transmission. J. Virol. 78:9064-9072.
46. Peeples ME. 1991. Paramyxovirus M proteins: pulling it all together and taking it on the road. Plenum Press, New York, NY.
47. Petrakova O, et al. 2005. Noncytopathic replication of Venezuelan equine encephalitis virus and eastern equine encephalitis virus replicons in mammalian cells. J. Virol. 79:7597-7608.
48. Pringle CR. 1987. Progress towards control of the acute respiratory viral diseases of childhood. Bull. World Health Organ. 65:133-137.
49. Radhakrishnan A, et al. 2010. Protein analysis of purified respiratory syncytial virus particles reveals an important role for heat shock protein 90 in virus particle assembly. Mol. Cell. Proteomics 9:1829-1848.
50. Rixon HW, et al. 2004. The small hydrophobic (SH) protein accumulates within lipid-raft structures of the Golgi complex during respiratory syncytial virus infection. J. Gen. Virol. 85:1153-1165.
51. Roberts SR, Compans RW, Wertz GW. 1995. Respiratory syncytial virus matures at the apical surfaces of polarized epithelial cells. J. Virol. 69: 2667-2673.
52. Rodriguez L, Cuesta I, Asenjo A, Villanueva N. 2004. Human respiratory syncytial virus matrix protein is an RNA-binding protein: binding properties, location and identity of the RNA contact residues. J. Gen. Virol. 85:709-719.
53. Santangelo PJ, Bao G. 2007. Dynamics of filamentous viral RNPs prior to egress. Nucleic Acids Res. 35:3602-3611.
54. Schmitt AP, Lamb RA. 2004. Escaping from the cell: assembly and budding of negative-strand RNA viruses. Curr. Top. Microbiol. Immunol. 283:145-196.
55. Stope MB, Karger A, Schmidt U, Buchholz UJ. 2001. Chimeric bovine respiratory syncytial virus with attachment and fusion glycoproteins replaced by bovine parainfluenza virus type 3 hemagglutininneuraminidase and fusion proteins. J. Virol. 75:9367-9377.
56. Takimoto T, Portner A. 2004. Molecular mechanism of paramyxovirus budding. Virus Res. 106:133-145.
57. Tayyari F, et al. 2011. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat. Med. 17:1132-1135.
58. Teng MN, Collins PL. 1998. Identification of the respiratory syncytial virus proteins required for formation and passage of helper-dependent infectious particles. J. Virol. 72:5707-5716.
59. Ulloa L, Serra R, Asenjo A, Villanueva N. 1998. Interactions between cellular actin and human respiratory syncytial virus (HRSV). Virus Res. 53:13-25.
60. Utley TJ, et al. 2008. Respiratory syncytial virus uses a Vps4-independent budding mechanism controlled by Rab11-FIP2. Proc. Natl. Acad. Sci. U. S. A. 105:10209-10214.